Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2021 | Story Michelle Nöthling | Photo Supplied
Emily Matabane.

“I love teaching hearing people Sign Language,” Emily immediately mentions when asked about herself, “so that they can communicate with Deaf people and work with them.” Part of her passion, though, was borne from personal hardship. Emily had a difficult experience when she entered the work environment in 2000, since she was the only Deaf person among an all-hearing staff. Can one even begin to imagine the frustration and isolation she must have experienced? It is no wonder, then, that her vision is for Deaf people to have equal access to information, and for the hearing and Deaf to be able to communicate with each other more freely. And the latter she is pursuing with all her energy.

“When I started working as a Teaching Assistant in the UFS Department of South African Sign Language (SASL) and Deaf Studies,” Emily recalls, “few students were interested in studying Sign Language, because they were not aware of Deaf people and Sign Language.” This has started to change, though, as Emily is noticing a drastic increase in the number of UFS students enrolling for SASL. “I am now familiar with a lot of hearing student who have done Sign Language at our university, and they are very friendly when I meet them. Also, because they are able to greet me in Sign Language!” It is important to note that the department teaches SASL modules to both Deaf and hearing students (and staff) who want to learn the language – which is now also available as an online option.

As a second-year student studying BEd, Emily has formed a close relationship with CUADS (Centre for Universal Access and Disability Support) at the UFS. “CUADS is doing a great job in assisting students with disabilities and catering for their needs. They assist students to have access to education on the same level as other students without disabilities.”

Sign Language is of vital importance to the Deaf community, since it is the language of accessibility for Deaf people. “We are proud and acknowledge Sign Language as a medium of communication,” says Emily. “It allows us to express ourselves, and to teach and transfer our Deaf culture from one generation to the other.”

Ultimately, Emily is hopeful that Sign Language will become embraced, celebrated, and recognised as equal to the other official languages in South Africa.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept